Fund Description

As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life¹. VanEck’s Medical Robotics and Bionic Engineering ETF tracks the performance of the portfolio of innovative companies that operate in medical technology – spanning medical robotics, bioprinting, advanced implants prosthesis, and organ and tissue preservation. The Fund has a sustainable investment objective, with an emphasis on social objectives:

• Invest in companies at the forefront of improving quality of life for the world’s ageing population
• Gain diversified exposure to companies involved in medical robotics implants and bionic enhancements for chronic diseases and functional impairments
• Access companies earning at least half their revenues from medical robotics and bionic engineering-related industries
• Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco

¹Source: McKinsey & Company. McKinsey Technology Trends Outlook 2025. July 2025.

Main Risk Factors: Equity market risk, industry or sector concentration risk, Liquidity Risks. Investors must consider all the fund's characteristics or objectives as detailed in the prospectus or related documents before making an investment decision. Please refer to the sustainability-related disclosures in the document section, to the

and the Prospectus for other important information before investing.